Experts in healthcare reimbursement and regulation,
providing customized consulting
and education services.

Training Programs

We bring the experts to you with a range of on-site education options and bootcamp style programs that teach how a firm grasp of the rules leads to operational excellence.

More information »

Audits & Assessments

Our team of specialized regulatory specialists can assist your organization in revving up your revenue cycle by auditing and assessing key processes for coding and billing.

More information »

Regulatory Monitoring

Our team is available for ongoing regulatory watchdog services that answer your questions and offer you the latest Medicare news, analysis and operational guidance.

More information »

Nov
10

Standing orders for drugs and biologicals

Email This Post Print This Post

CMS, in a letter to state survey agency directors dated October 24, revised interpretive guidelines clarifying that hospitals may use standing orders and written protocols for drugs or biologicals.

CMS also clarified that the practitioner who is responsible for a patient’s care should write and sign standing orders in that patient’s chart. However, the timing of the documentation should not be a barrier to effective emergency response, timely and necessary care, or other patient safety advances.

CMS states that it expects practitioners to enter the standing order into the order entry section of a patient’s medical record as soon as possible after implementation of the order (much like a verbal order would be entered), and that the patient’s physician must authenticate the order.

To view the CMS letter, click here.

Leave a Reply